(Q38088426)

28 August 2017

Vulvar and vaginal melanoma: case series and review of current management options including neoadjuvant chemotherapy (English)

1 reference

28 August 2017

neoadjuvant chemotherapy

1 reference

1 reference

3

Amy L Weaver

1 reference

28 August 2017

Jo Marie Tran Janco

1

1 reference

28 August 2017

Svetomir N Markovic

series ordinal

2

1 reference

28 August 2017

William A Cliby

series ordinal

4

1 reference

28 August 2017

language of work or name

English

0 references

publication date

26 February 2013

1 reference

28 August 2017

1 reference

28 August 2017

129

1 reference

28 August 2017

3

1 reference

28 August 2017

533-537

1 reference

The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society

28 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960-1984

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Primary malignant melanoma of the vagina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Neoadjuvant therapy for high-risk bulky regional melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Melanoma of the vulva: an update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Surgical resection for bulky or recurrent axillary metastatic melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Rationale for complete metastasectomy in patients with stage IV metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Malignant melanoma of the vulva: an extension of cutaneous melanoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Vulvar melanoma: a retrospective analysis and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Conservative therapy for melanoma of the vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Malignant melanoma of the vulva: a clinicopathological study of 50 women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Management of vulvar melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Malignant melanoma of the female genital system: a report of 48 patients and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Vulvar melanoma: is there a role for sentinel lymph node biopsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Malignant melanoma of the vulva treated by radical hemivulvectomy. A prospective study of the Gynecologic Oncology Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Adjuvant therapy for melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Malignant melanoma of the vagina and locoregional control: radical surgery revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

Clinicopathologic study of 85 cases of melanoma of the female genitalia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.02.028

10.1016/J.YGYNO.2013.02.028

7 January 2021

Identifiers

DOI

1 reference

28 August 2017

1 reference